You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
平安好医生(01833.HK)推医药新零售战略产品「药诊付」
阿思达克 05-14 11:30
平安好医生(01833.HK)宣布,计划融合商业保险打造医药新零售模式,推出创新战略产品「药诊付」,以在线医疗服务为核心,为药店和药企提供服务、实物、保险、系统与数据四大产品,解决用户诊疗、购药及支付三大问题。

主席兼首席执行官方蔚豪透露,药诊付建立原研药、进口药等药品商保目录,满足患者用药需求,目前覆盖全国近30个省级行政区,近300个地级市,打通近千家连锁药房及5万家药店。

他又指,平安好医生通过打通自建大仓、中心仓、O2O等网络渠道,建立线上线下综合生态圈,药店云问诊合作药店数目已达15.1万家,覆盖全国32个省级行政区、379个城市,并与超过4,000家连锁药店品牌展开合作,与近千家药企建立供应链合作,其供应链品种超过6,000种。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account